|
Name |
trans-4-Methyl-2-pentene
|
Molecular Formula | C6H12 | |
IUPAC Name* |
(E)-4-methylpent-2-ene
|
|
SMILES |
C/C=C/C(C)C
|
|
InChI |
InChI=1S/C6H12/c1-4-5-6(2)3/h4-6H,1-3H3/b5-4+
|
|
InChIKey |
LGAQJENWWYGFSN-SNAWJCMRSA-N
|
|
Synonyms |
trans-4-Methyl-2-pentene; 674-76-0; (E)-4-Methyl-2-pentene; (E)-4-Methylpent-2-ene; 4-METHYL-2-PENTENE; 2-Pentene, 4-methyl-; 2-Pentene, 4-methyl-, (E)-; 4-Methyl-trans-2-pentene; (2E)-4-methylpent-2-ene; 4-Methyl-2-pentene, (2E)-; 1,1-Dimethyl-2-butene; M38LU0DQ4J; (2E)-4-Methyl-2-pentene; NSC-73914; 2-Methyl-3-pentene; UNII-M38LU0DQ4J; MFCD00065138; EINECS 211-616-6; EINECS 224-721-7; trans-4-methylpentene-2; 4-Methyl-2-pentene,c&t; 4-Methyl-2-pentene(c,t); 4-Methylpentene-2, trans-; 4-Methyl-2-pentene, trans-; 4-Methyl-2-pentene, (E)-; (2E)-4-Methyl-2-pentene #; TRANS-2-METHYL-3-PENTENE; (E)-(CH3)2CHCH=CHCH3; DTXSID101015956; 2-Pentene, 4-methyl-, (2E)-; NSC73914; ZINC1699375; NSC 19873; NSC 73914; AKOS025295620; 2-PENTENE, 4-METHYL-, TRANS-; M0394; trans-4-Methyl-2-pentene, technical, >=90% (GC); Q27283426
|
|
CAS | 674-76-0 | |
PubChem CID | 172092 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 84.16 | ALogp: | 2.4 |
HBD: | 0 | HBA: | 0 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 0.0 | Aromatic Rings: | 0 |
Heavy Atoms: | 6 | QED Weighted: | 0.428 |
Caco-2 Permeability: | -4.147 | MDCK Permeability: | 0.00002720 |
Pgp-inhibitor: | 0 | Pgp-substrate: | 0.003 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.026 |
30% Bioavailability (F30%): | 0.57 |
Blood-Brain-Barrier Penetration (BBB): | 0.981 | Plasma Protein Binding (PPB): | 96.39% |
Volume Distribution (VD): | 3.195 | Fu: | 4.46% |
CYP1A2-inhibitor: | 0.702 | CYP1A2-substrate: | 0.761 |
CYP2C19-inhibitor: | 0.122 | CYP2C19-substrate: | 0.918 |
CYP2C9-inhibitor: | 0.09 | CYP2C9-substrate: | 0.866 |
CYP2D6-inhibitor: | 0.024 | CYP2D6-substrate: | 0.402 |
CYP3A4-inhibitor: | 0.023 | CYP3A4-substrate: | 0.313 |
Clearance (CL): | 7.521 | Half-life (T1/2): | 0.579 |
hERG Blockers: | 0.007 | Human Hepatotoxicity (H-HT): | 0.06 |
Drug-inuced Liver Injury (DILI): | 0.08 | AMES Toxicity: | 0.013 |
Rat Oral Acute Toxicity: | 0.018 | Maximum Recommended Daily Dose: | 0.097 |
Skin Sensitization: | 0.187 | Carcinogencity: | 0.056 |
Eye Corrosion: | 0.98 | Eye Irritation: | 0.995 |
Respiratory Toxicity: | 0.039 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001828 | 0.357 | D0M1PQ | 0.171 | ||||
ENC001703 | 0.316 | D03LGG | 0.169 | ||||
ENC002241 | 0.265 | D0U5CE | 0.169 | ||||
ENC000619 | 0.250 | D0B2OT | 0.167 | ||||
ENC000147 | 0.238 | D0ZK8H | 0.167 | ||||
ENC000906 | 0.233 | D04CSZ | 0.158 | ||||
ENC000382 | 0.231 | D06GIP | 0.158 | ||||
ENC000237 | 0.231 | D0T3NY | 0.143 | ||||
ENC001734 | 0.229 | D0A3HB | 0.140 | ||||
ENC001735 | 0.229 | D07ZTO | 0.135 |